These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38314181)

  • 1. Choosing Therapies in Ulcerative Colitis.
    Das R; Steinhart AH
    J Can Assoc Gastroenterol; 2024 Feb; 7(1):9-21. PubMed ID: 38314181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts.
    Ungaro RC; Limketkai BN; Jensen CB; Allin KH; Agrawal M; Ullman T; Colombel JF; Jess T
    Gut; 2019 Jun; 68(6):977-984. PubMed ID: 30420398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
    PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mesalamine in the treatment of ulcerative colitis.
    Karagozian R; Burakoff R
    Ther Clin Risk Manag; 2007 Oct; 3(5):893-903. PubMed ID: 18473013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.
    Johnsen KM; Florholmen J; Moe ØK; Gundersen M; Beilfuss J; Kileng H; Sørbye SW; Goll R
    BMC Gastroenterol; 2022 Nov; 22(1):459. PubMed ID: 36384477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for the treatment of inflammatory bowel disease.
    Wong U; Cross RK
    Expert Opin Emerg Drugs; 2022 Dec; 27(4):369-377. PubMed ID: 36369862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom.
    Lindsay JO; Picker N; Kromer D; Smyth M; Patel H
    Curr Med Res Opin; 2023 May; 39(5):681-689. PubMed ID: 36951899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for the induction and maintenance of remission in ulcerative colitis.
    Gordon M; Sinopoulou V; Grafton-Clarke C; Akobeng AK
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013743. PubMed ID: 35583095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
    Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New lessons: classic treatments, expanding options in ulcerative colitis.
    Hanauer SB
    Colorectal Dis; 2006 May; 8 Suppl 1():20-4. PubMed ID: 16594960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
    Yen L; Wu J; Hodgkins PL; Cohen RD; Nichol MB
    J Manag Care Pharm; 2012; 18(9):701-12. PubMed ID: 23206213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
    Regueiro M; Loftus EV; Steinhart AH; Cohen RD
    Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.